BSE Live
Dec 29, 16:01Prev. Close
1101.45
Open Price
1101.45
Bid Price (Qty.)
1136.30 (192)
Offer Price (Qty.)
1150.00 (4)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 54.14 | 31.10 | 25.57 | 161.57 | 21.27 | |
| Net CashFlow From Operating Activities | 52.72 | 42.98 | 41.38 | 64.46 | 26.71 | |
| Net Cash Used In Investing Activities | -28.52 | -26.40 | -48.44 | -62.98 | -23.20 | |
| Net Cash Used From Financing Activities | -14.44 | -17.40 | 0.99 | 5.66 | 0.77 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 9.76 | -0.81 | -6.07 | 7.14 | 4.27 | |
| Cash And Cash Equivalents Begin of Year | 2.26 | 3.07 | 9.13 | 5.81 | 1.54 | |
| Cash And Cash Equivalents End Of Year | 12.02 | 2.26 | 3.07 | 12.95 | 5.81 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y